{
    "organizations": [],
    "uuid": "36a5e4b6cb606f41f78663c74b23540bd7f4f652",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-global-blood-therapeutics-priced-u/brief-global-blood-therapeutics-priced-underwritten-public-offering-of-4-0-mln-shares-of-its-common-stock-idUSASB0C9NG",
    "ord_in_thread": 0,
    "title": "BRIEF-Global Blood Therapeutics ‍priced underwritten public offering of 4.0 mln shares of its common stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Global Blood Therapeutics Inc:\n* GLOBAL BLOOD THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF 4,000,000 SHARES OF COMMON STOCK\n* GLOBAL BLOOD THERAPEUTICS INC-‍PRICED AN UNDERWRITTEN PUBLIC OFFERING OF 4.0 MILLION SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $54.00 PER SHARE​ Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-09T11:17:00.000+02:00",
    "crawled": "2018-03-09T07:17:31.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "global",
        "blood",
        "therapeutic",
        "inc",
        "global",
        "blood",
        "therapeutic",
        "announces",
        "pricing",
        "public",
        "offering",
        "share",
        "common",
        "stock",
        "global",
        "blood",
        "therapeutic",
        "underwritten",
        "public",
        "offering",
        "million",
        "share",
        "common",
        "stock",
        "price",
        "public",
        "per",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}